All Articles

Dr Neal Shore introduces the current global landscape of various imaging modalities for prostate cancer, including a new prostate-specific membrane antigen (PSMA)-targeted PET/CT agent, PYLARIFY^® (piflufolastat F 18).

Diagnostic Capability in Relapsed Prostate Cancer Improved with ¹⁸F-DCFPyL PET/CT Imaging

Prostate Cancer

Web Exclusives

Recently released analysis of ¹⁸F-DCFPyL PET/CT accuracy demonstrated improved diagnostic capability in men with biochemical recurrence of prostate cancer.

NaF PET Imaging Demonstrates Increased Sensitivity for New Lesion Detection for Patients with Metastatic Prostate Cancer

Prostate Cancer

Web Exclusives

NaF PET imaging study demonstrates an increased sensitivity over Tc99m-MDP bone scans for new lesion detection in patients with stable metastatic prostate cancer.

Recent Study Results Finds ¹⁸F-Fluciclovine PET/CT Alters Recurrent Prostate Cancer Management

Prostate Cancer

Web Exclusives

Salvage radiotherapy decisions for patients with recurrent prostate cancer after prostatectomy change after ¹⁸F-fluciclovine PET/CT reveals higher positive findings than conventional imaging.

Multicenter International Prospective Trial on Gallium-68 PSMA PET/CT Imaging Confirms Accuracy in Detecting Prostate Cancer Recurrence

Prostate Cancer

Web Exclusives

Gallium-68 PSMA PET/CT imaging in patients with early relapsed prostate cancer confirms the reliability of this imaging modality in local and metastatic lesion detection.

Whole-Body MRI Found Superior to Bone Scan for Prognosis in Patients with Metastatic Prostate Cancer

Prostate Cancer

Web Exclusives

Recently released study results indicate whole-body MRI is superior to bone scan for prognosis in patients with metastatic hormone-naïve prostate cancer.

The Countdown to the AONN+ Annual Conference!

By Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG

Letters from Lillie

October 2021 Vol 12, No 10

Addressing Barriers to Fertility Preservation for Cancer Patients: The Role of Oncofertility Patient Navigation

By Caroline S. Dorfman, PhD; Juliann M. Stalls, PhD; Coleman Mills, MA; Shannon Voelkel, BS; Mallori Thompson, MA; Kelly S. Acharya, MD; Karen C. Baker, MD; Lars M. Wagner, MD; Nolan Miller, MHA; Amy Boswell, MSN; Cheyenne Corbett, PhD

Original Research, Fertility, Barriers to Care

October 2021 Vol 12, No 10

The authors discuss key strategies to address the multilevel barriers to fertility preservation for oncology patients.

FGFR Inhibitors in the Treatment of Patients with Advanced CCA: A Nursing Perspective. Highlights from a Virtual Symposium Cholangiocarcinoma

Cholangiocarcinoma

October 2021 Vol 12, No 10